Understand the source comparison
SS-LUP-332 Endurance: Comparison of Metabolic Modulators
Before analyzing specific mechanisms, understanding how SS-LUP-332 endurance effects compare to established metabolic modulators clarifies where the compound fits in the broader landscape of performance research. The table below compares mechanism, duration of
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before analyzing specific mechanisms, understanding how SS-LUP-332 endurance effects compare to established metabolic modulators clarifies where the compound fits in the broader landscape of performance research. The table below compares mechanism, duration of effect, and metabolic profile across representative compounds from different mechanistic classes.
- SS-LUP-332
- ERRα agonist. Transcriptional upregulation of oxidative metabolism genes
- 7–10 days (mitochondrial proteins persist after dosing stops)
- Shifts crossover point from 45% to 62% VO2max; increases fat oxidation at submaximal intensities
- +34% mitochondrial density, +52% palmitate oxidation after 28 days
- Most closely mimics chronic training adaptation; effects persist beyond acute dosing window
- GW501516 (Cardarine)
- PPARδ agonist. Fatty acid oxidation and mitochondrial biogenesis
- 3–5 days (shorter half-life, faster washout)
- Increases fat oxidation; spares glycogen during prolonged exercise
- +30% mitochondrial content in rodent models; similar magnitude to SS-LUP-332
- Withdrawn from development due to carcinogenicity signals in 2-year rodent studies; not viable for long-term use
- AICAR
- AMPK activator. Mimics low-energy state to trigger adaptation
- 24–48 hours (effects dependent on sustained AMPK activation)
- Increases glucose uptake and fat oxidation acutely
- Minimal direct mitochondrial biogenesis without chronic dosing
- Acute metabolic activation without structural adaptation; used primarily in short-term research models
- Beta-alanine
- Increases muscle carnosine. Buffers hydrogen ions
- Weeks (carnosine accumulates slowly, depletes slowly)
- No direct substrate shift; improves lactate tolerance at high intensity
- No mitochondrial effect; mechanism is buffering rather than oxidative
- Effective for high-intensity efforts (1–4 minutes); minimal impact on aerobic endurance capacity
- Caffeine
- Adenosine receptor antagonist. CNS stimulation
- 4–6 hours (acute performance window)
- Increases fat oxidation via catecholamine release; CNS-mediated
- No mitochondrial adaptation; purely acute pharmacological effect
- Reliable acute performance enhancer for perception of effort; no chronic adaptation